# Dexmedetomidine and Liver Transplantation

> **NCT03770130** · EARLY_PHASE1 · COMPLETED · sponsor: **RenJi Hospital** · enrollment: 330 (actual)

## Conditions studied

- Dexmedetomidine, Liver Transplantation, Allograft Function, Survival

## Interventions

- **DRUG:** Dexmedetomidine
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT03770130
- **Lead sponsor:** RenJi Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-14
- **Primary completion:** 2022-10-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 330 (ACTUAL)
- **Last updated:** 2023-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03770130

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03770130, "Dexmedetomidine and Liver Transplantation". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03770130. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*